Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $35.5 million.

  • Voyager Therapeutics' Total Current Liabilities fell 1971.27% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year decrease of 1971.27%. This contributed to the annual value of $49.8 million for FY2024, which is 2281.89% down from last year.
  • Latest data reveals that Voyager Therapeutics reported Total Current Liabilities of $35.5 million as of Q3 2025, which was down 1971.27% from $42.0 million recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Total Current Liabilities ranged from a high of $101.7 million in Q1 2022 and a low of $19.9 million during Q1 2023
  • Over the past 5 years, Voyager Therapeutics' median Total Current Liabilities value was $45.4 million (recorded in 2023), while the average stood at $52.0 million.
  • In the last 5 years, Voyager Therapeutics' Total Current Liabilities skyrocketed by 31079.96% in 2022 and then crashed by 8038.99% in 2023.
  • Over the past 5 years, Voyager Therapeutics' Total Current Liabilities (Quarter) stood at $51.0 million in 2021, then skyrocketed by 42.39% to $72.6 million in 2022, then dropped by 11.13% to $64.5 million in 2023, then dropped by 22.82% to $49.8 million in 2024, then dropped by 28.71% to $35.5 million in 2025.
  • Its Total Current Liabilities stands at $35.5 million for Q3 2025, versus $42.0 million for Q2 2025 and $40.2 million for Q1 2025.